SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001615774-18-007626
Filing Date
2018-08-07
Accepted
2018-08-06 21:59:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15356
2 PART II AND III s111621_partiiandiii.htm PART II AND III 928455
3 EXHIBIT 1.1 s111621_ex1-1.htm EX1A-1 UNDR AGMT 210708
4 EX1A-4 SUBS AGMT s111621_ex4-3.htm EX1A-4 SUBS AGMT 117013
5 EXHIBIT 11.1 s111621_ex11-1.htm EX1A-11 CONSENT 3572
6 GRAPHIC img001_v1.jpg GRAPHIC 5347
7 GRAPHIC img002_v1.jpg GRAPHIC 61528
8 GRAPHIC img003_v1.jpg GRAPHIC 70076
9 GRAPHIC img004_v1.jpg GRAPHIC 54389
10 GRAPHIC img005_v1.jpg GRAPHIC 38143
  Complete submission text file 0001615774-18-007626.txt   1592943
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10825 | Film No.: 18996166
SIC: 2834 Pharmaceutical Preparations